Vaccination policies in the military: An insight on influenza

Vaccine

Volumn 20, Issue SUPPL. 5, 2002, Pages

  D'Amelio, Raffaele ^a,b   Biselli, Roberto ^c   Calì, Glauco ^d   Peragallo, Mario Stefano ^e  

^a II Facolta di Medicina e Chirurgia   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Reparto Medicina Aeronautica e Spaziale   (Italy)

^d Ministero della Difesa Stato Maggiore della Difesa   (Italy)

^e Centro Studi e Ricerche di Sanit e Veterinaria Militare   (Italy)

Author keywords

Influenza; Military; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ABSENTEEISM; ANTIGENIC VARIATION; COST EFFECTIVENESS ANALYSIS; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MORTALITY; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REVIEW; SOLDIER; VACCINATION; WORLD HEALTH ORGANIZATION; ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS; IMMUNOLOGY; INFORMATION PROCESSING; MANDATORY PROGRAM; PRACTICE GUIDELINE; VOLUNTARY PROGRAM;

COST-BENEFIT ANALYSIS; DATA COLLECTION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MANDATORY PROGRAMS; MILITARY PERSONNEL; PRACTICE GUIDELINES; VACCINATION; VOLUNTARY PROGRAMS; WORLD HEALTH ORGANIZATION;

EID: 0037146954     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00506-6     Document Type: Short Survey

References (23)

1. WHO fact sheet. Influenza. Fact sheet no. 211. Geneva: WHO HQ; February 1999.
2. Gaydos J.C., Hodder R.A., Top F.H. Jr.et al. Swine influenza A at Fort Dix, New Jersey (January-February 1976). I. Case finding and clinical study of cases. J. Infect. Dis. 136(Suppl.):1977;S356-S362.
3. Update: Isolation of avian influenza A (H5N1) viruses from humans - Hong Kong, 1997-1998. MMWR Morb Mortal Wkly Rep 1998;46:1245-7.
4. Peiris M., Yuen K.Y., Leung C.W.et al. Human infection with influenza H9N2. Lancet. 354:1999;916-917.
5. World Health Organization influenza programme: http://www.who.int/emc/diseases/flu/index.html .
6. Considerations for distinguishing Influenza-like illness from Inhalational anthrax. MMWR Morb Mortal Wkly Rep 2001;50:984-6.
7. Gray G.C., Callahan J.D., Hawksworth A.W., Fisher C.A., Gaydos J.C. Respiratory diseases among US military personnel: countering emerging threats. Emerg. Infect. Dis. 5:1999;379-387.
8. Seal J.R. Reactions to influenza vaccine. US Armed Forces Med. J. 6:1955;1559-1563.
9. Earhart K.C., Beadle C., Miller L.K.et al. Outbreak of influenza in highly vaccinated crew of US Navy Ship. Emerg. Infect. Dis. 7:2001;463-465.
10. Canas L.C., Lohman K., Pavlin J.A.et al. The Department of Defense Laboratory-based global influenza surveillance system. Mil. Med. 165(Suppl. 2):2000;52-56.
11. Rocchi G., Ragona G., Piga C.et al. Influenza vaccination with live-attenuated and inactivated virus-vaccines during an outbreak of disease. J. Hyg. 83:1979;383-390.
12. Lee Sh., Rozer K.R., MacDonald M.et al. Influenza B outbreak at a Canadian Forces Base - Nova Scotia. Can. Dis. Wkly. Rep. 14:1988;82.
13. Kuhn M., Flury G., Germann D., Gartmann J. Radiological lung changes during an influenza epidemic in two schools for Army recruits. Schweiz Rundsch Med. Prax. 76:1987;547-550.
14. Mombaerts-Servais M., van Vliet-Husson J. Survey of influenza in Belgium 1980-2001. Performance of serologic studies on military recruits. Arch. Belg. Med. Soc. 39:1981;498-506.
15. Koufman Z., Egoz N., Rannon L. Efficacy of inactivated influenza vaccine in two outbreaks in military units. Harefnah. 94:1978;9-11.
16. Scientific and Technical Evaluation of Vaccination Programmes in the European Union. Euvax Project Report. Helsinki: PSR Consulting Ltd.; 2001.
17. D'Amelio R., Heymann D.L. Can the military contribute to global surveillance and control of infectious diseases? Emerg. Infect. Dis. 4:1998;704-705.
18. D'Amelio R, Heymann DL. A worldwide epidemiological survey on the infrastructure for prevention of communicable diseases in the military. In: Proceedings of the Conference AGARD 599 "Aeromedical Support Issues in Contingency Operations" NATO. September 1998. p. 42.1-5.
19. D'Amelio R: Technical evaluation report. In: Proceedings of the AGARD 518 "Allergic, Immunological and Infectious Disease Problems in Aerospace Medicine" NATO. April 1992. p. T1-12.
20. Postma M.J., Bos J.M., van Gennep M., Jager J.C., Baltussen R., Sprenger M.J. Economic evaluation of influenza vaccination. Assessment for The Netherlands. Pharmacoeconomics. 16(Suppl. 1):1999;33-40.
21. Wood S.C., Nguyen V.H., Schmidt C. Economic evaluations of influenza vaccination in healthy working-age adults. Employer and society perspective. Pharmacoeconomics. 18:2000;173-183.
22. Bridges C.B., Thompson W.W., Meltzer M.I.et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomised controlled trial. J. Am. Med. Assoc. 284:2000;1655-1663.
23. Nichol K.L. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch. Intern. Med. 161:2001;749-759.